Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.
Interleukin (IL)-17 is emerging as an important cytokine in vaccine-induced protection against tuberculosis disease in animal models. Here we show that compared to parenteral delivery, BCG delivered mucosally enhances cytokine production, including interferon gamma and IL-17, in the lungs. Furthermo...
Main Authors: | Kristin L Griffiths, Elena Stylianou, Hazel C Poyntz, Gareth J Betts, Helen A Fletcher, Helen McShane |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3806838?pdf=render |
Similar Items
-
Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
by: Gareth Betts, et al.
Published: (2012-01-01) -
Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
by: Angela M Minassian, et al.
Published: (2011-01-01) -
Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
by: Kristin L Griffiths, et al.
Published: (2011-01-01) -
Local Pulmonary Immunological Biomarkers in Tuberculosis
by: Hazel Morrison, et al.
Published: (2021-03-01) -
Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.
by: Lech Ignatowicz, et al.
Published: (2012-01-01)